Alfasigma acquires Nordic Group B.V. and expands its presence in Europe
ROMA (ITALPRESS) – The Alfasigma pharmaceutical company today announced that it has signed an agreement with SEVER Life Sciences B.V. (“SEVER”) for the sale of 100% of the shares of Nordic Group B.V and its subsidiaries (Nordic Pharma). Nordic Pharma […]
Alfasigma acquires Nordic Group B.V. and expands its presence in Europe Read More »










